BioCentury
ARTICLE | Company News

Juvenescence, Buck Institute launch company to research ketones for age-related diseases

February 8, 2019 1:48 AM UTC

Juvenescence Ltd. (Douglas, Isle of Man) and the Buck Institute for Research on Aging (Novato, Calif.) partnered to form BHB Therapeutics Ltd. The new company will focus on novel approaches to inducing a state of ketosis to protect against age-related diseases.

BHB is based on research from the Buck Institute President and CEO Eric Verdin's lab, centered on the emerging signaling functions of a metabolite created by the body during fasting or exercise, the ketone body beta-hydroxybutyrate (BHB)...